JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120464

Dynole® 31-2, Negative control for Dynolereg 34-2

Be the first to review this product! Submit a review

|

(7 Publications)

MW 338.45 g/mol, Purity >97%. Negative control molecule for use with Dynole® 34-2 ab120463. Displays no significant activity at dynamin I or II (up to 300 µM).
3 Images
Immunocytochemistry/ Immunofluorescence - Dynole® 31-2, Negative control for Dynolereg 34-2 (AB120464)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Dynole® 31-2, Negative control for Dynolereg 34-2 (AB120464)

ab66705 staining PAI1 in HeLa cells treated with dynole-31-2™ (ab120464), by ICC/IF. No change in PAI1 expression with increased concentration of dynole-31-2™ (negative control for dynole 34-2™ (ab120463), as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120464 (dynole-31-2™) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab66705 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Functional Studies - Dynole® 31-2, Negative control for Dynolereg 34-2 (AB120464)
  • FuncS

PubMed

Functional Studies - Dynole® 31-2, Negative control for Dynolereg 34-2 (AB120464)

Dynamin2 regulates integrin-mediated T lymphocyte adhesion under laminar flow.

End point quantification of T lymphocyte adhesion following treatment of the cells with either Dynole 31–2 as a control or Dynole 34–2 to inhibit dynamin2 activity (n = 6)

(From Figure 2D of Eppler et al).

Eppler et al PLoS One. 2017; 12(3): e0172443. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/

Chemical Structure - Dynole® 31-2, Negative control for Dynolereg 34-2 (AB120464)
  • Chemical Structure

Lab

Chemical Structure - Dynole® 31-2, Negative control for Dynolereg 34-2 (AB120464)

2D chemical structure image of ab120464, Dynole® 31-2, Negative control for Dynolereg 34-2

Key facts

Purity

>97%

Form

Solid

form

Molecular weight

338.45 g/mol

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biological description

Negative control molecule for use with Dynole® 34-2 ab120463. Displays no significant activity at dynamin I or II (up to 300 µM).

Canonical smiles

CCCNC(=O)C(C#N)=CC2CN(CCCN(C)C)C1CCCCC12

InChi

InChI=1S/C20H26N4O/c1-4-10-22-20(25)16(14-21)13-17-15-24(12-7-11-23(2)3)19-9-6-5-8-18(17)19/h5-6,8-9,13,15H,4,7,10-12H2,1-3H3,(H,22,25)/b16-13+

InChiKey

NOOFIXCUBMYDIB-DTQAZKPQSA-N

IUPAC Name

2-Cyano-N-propyl-3-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]acrylamide

Product details

Sold under exclusive licence from Children's Medical Research Institute and Newcastle Innovation Ltd. Dynole® is a trademark of Children's Medical Research Institute and Newcastle Innovation Ltd.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Science signaling 11: PubMed30065026

2018

Contact inhibitory Eph signaling suppresses EGF-promoted cell migration by decoupling EGFR activity from vesicular recycling.

Applications

Unspecified application

Species

Unspecified reactive species

Wayne Stallaert,Yannick Brüggemann,Ola Sabet,Lisa Baak,Marina Gattiglio,Philippe I H Bastiaens

Scientific reports 7:4580 PubMed28676641

2017

Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells.

Applications

Unspecified application

Species

Unspecified reactive species

Arlek M González-Jamett,Ximena Baez-Matus,María José Olivares,Fernando Hinostroza,Maria José Guerra-Fernández,Jacqueline Vasquez-Navarrete,Mai Thao Bui,Pascale Guicheney,Norma Beatriz Romero,Jorge A Bevilacqua,Marc Bitoun,Pablo Caviedes,Ana M Cárdenas

PloS one 12:e0172443 PubMed28273099

2017

Dynamin2 controls Rap1 activation and integrin clustering in human T lymphocyte adhesion.

Applications

Unspecified application

Species

Unspecified reactive species

Felix J Eppler,Thomas Quast,Waldemar Kolanus

Cellular signalling 28:160-71 PubMed26475677

2015

Impaired dynamin 2 function leads to increased AP-1 transcriptional activity through the JNK/c-Jun pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ewelina Szymanska,Agnieszka Skowronek,Marta Miaczynska

PLoS pathogens 9:e1003309 PubMed23593008

2013

Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein.

Applications

Unspecified application

Species

Unspecified reactive species

Magdalena Anna Krzyzaniak,Michael Thomas Zumstein,Juan Atilio Gerez,Paola Picotti,Ari Helenius

Retrovirology 8:99 PubMed22145853

2011

Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.

Applications

Unspecified application

Species

Unspecified reactive species

Michelle de la Vega,Mariana Marin,Naoyuki Kondo,Kosuke Miyauchi,Yuri Kim,Raquel F Epand,Richard M Epand,Gregory B Melikyan

The Biochemical journal 440:185-93 PubMed21895608

2011

Intracellular curvature-generating proteins in cell-to-cell fusion.

Applications

Unspecified application

Species

Unspecified reactive species

Jean-Philippe Richard,Evgenia Leikina,Ralf Langen,William Mike Henne,Margarita Popova,Tamas Balla,Harvey T McMahon,Michael M Kozlov,Leonid V Chernomordik
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com